UBS Group AG - BRICKELL BIOTECH INC ownership

BRICKELL BIOTECH INC's ticker is BBI and the CUSIP is 10802T105. A total of 31 filers reported holding BRICKELL BIOTECH INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BRICKELL BIOTECH INC
ValueSharesWeighting
Q2 2022$22,000
+266.7%
173,638
+688.9%
0.00%
Q1 2022$6,000
-14.3%
22,010
-30.4%
0.00%
Q4 2021$7,000
-53.3%
31,601
+50.5%
0.00%
Q3 2021$15,000
-84.2%
21,000
-79.0%
0.00%
Q2 2021$95,00099,922
+1427357.1%
0.00%
Q1 2021$0
-100.0%
7
-99.8%
0.00%
Q4 2020$3,000
-90.0%
3,337
-90.1%
0.00%
Q3 2020$30,000
+900.0%
33,580
+4050.8%
0.00%
Q3 2019$3,0008090.00%
Other shareholders
BRICKELL BIOTECH INC shareholders Q3 2021
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 1,905,124$510,0000.80%
PALISADE CAPITAL MANAGEMENT, LP 970,547$260,0000.01%
JOURNEY STRATEGIC WEALTH LLC 105,042$28,0000.00%
WATER ISLAND CAPITAL LLC 100,000$27,0000.00%
THRIVENT FINANCIAL FOR LUTHERANS 61,508$14,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 1$00.00%
BANK OF AMERICA CORP /DE/ 313$00.00%
FIRST MANHATTAN CO. LLC. 14$00.00%
WELLS FARGO & COMPANY/MN 3,160$1,0000.00%
NORTHERN TRUST CORP 117,417$31,0000.00%
View complete list of BRICKELL BIOTECH INC shareholders